Targeting SWI/SNF ATPases in enhancer-addicted prostate cancerLanbo Xiao, Arul M. Chinnaiyan|Nature|2021Cited by 311
Targeting PIKfyve-driven lipid metabolism in pancreatic cancerCaleb Cheng, Arul M. Chinnaiyan, Yi Bao et al.|Nature|2025Cited by 37
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13Jean C. Tien, Arul M. Chinnaiyan, Jie Luo et al.|Cell Reports Medicine|2024Cited by 28
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancerTongchen He, Arul M. Chinnaiyan, Caleb Cheng et al.|Proceedings of the National Academy of Sciences|2024Cited by 22
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinomaJean C. Tien, Arul M. Chinnaiyan, Yali Zhai et al.|Proceedings of the National Academy of Sciences|2025Cited by 6